Form 4 for INKT MiNK Therapeutics, Inc.
Accepted 2023-10-06 00:00:00 ET · period of report 2023-10-04 · accession 0000950170-23-052408 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-06 | 2023-10-04 | INKT | AGENUS INC | 10% | P - Purchase | $1.09 | +15.0K | 21.75M | +0.1% | +$16.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-04 | P | A | 15,001 | $1.09 | 21,749,888 | D | — | — | (F2) Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F1) Open market purchases reported on this line occurred at a weighted average price of $1.0919 (range of $1.02 to $1.10). |